Helen Taylor
Directeur/Membre du Conseil chez The Royal Marsden Cancer Charity
Profil
Helen Taylor has a current job as a trustee at The Royal Marsden Cancer Charity.
Postes actifs de Helen Taylor
| Sociétés | Poste | Début |
|---|---|---|
The Royal Marsden Cancer Charity
 The Royal Marsden Cancer Charity Miscellaneous Commercial ServicesCommercial Services The Royal Marsden Cancer Charity is a non-profit organization that supports the Royal Marsden, a world-leading cancer center. The non-profit company is based in London, UK. The charity raises funds to provide state-of-the-art equipment, ground-breaking research, and the best patient environments to improve the lives of people affected by cancer. The Royal Marsden Cancer Charity pursues excellence in everything they do, from providing the very best care to developing life-saving treatments that are used around the world. Researchers at the Royal Marsden are working on technology to streamline the analysis of patient scans, speed up the detection of lung cancer, and fast-track high-risk patients to treatment. Antonia Dalmahoy has been the CEO of the British company since 2015. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
The Royal Marsden Cancer Charity
The Royal Marsden Cancer Charity Miscellaneous Commercial ServicesCommercial Services The Royal Marsden Cancer Charity is a non-profit organization that supports the Royal Marsden, a world-leading cancer center. The non-profit company is based in London, UK. The charity raises funds to provide state-of-the-art equipment, ground-breaking research, and the best patient environments to improve the lives of people affected by cancer. The Royal Marsden Cancer Charity pursues excellence in everything they do, from providing the very best care to developing life-saving treatments that are used around the world. Researchers at the Royal Marsden are working on technology to streamline the analysis of patient scans, speed up the detection of lung cancer, and fast-track high-risk patients to treatment. Antonia Dalmahoy has been the CEO of the British company since 2015. | Commercial Services |
